Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, July 20, 2018
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
[ Fri, Jul 20th 2018
] - WOPRAI
Thu, July 19, 2018
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
[ Thu, Jul 19th 2018
] - WOPRAI
Alethia Young Initiated (ANAB) at Buy and Held Target at $104 on, Jul 19th, 2018
Alethia Young of Credit Suisse, Initiated "AnaptysBio, Inc." (ANAB) at Buy and Held Target at $104 on, Jul 19th, 2018.
Alethia has made no other calls on ANAB in the last 4 months.
There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 1 agrees with Alethia's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Kennen MacKay of "RBC Capital" Downgraded from Buy to Hold on, Wednesday, April 4th, 2018
This is the rating of the analyst that currently disagrees with Alethia
- Alex Schwartz of "Stifel" Maintained at Strong Buy with Increased Target to $152 on, Tuesday, March 27th, 2018
Similar Stocks and Investing Articles
[ Thu, Jun 21st 2018
] - WOPRAI
[ Thu, Jun 21st 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Wed, Jun 20th 2018
] - WOPRAI
[ Tue, Jun 19th 2018
] - WOPRAI
[ Fri, Apr 27th 2018
] - WOPRAI
[ Thu, Oct 19th 2017
] - WOPRAI
[ Wed, Aug 23rd 2017
] - WOPRAI
[ Fri, Aug 18th 2017
] - WOPRAI